MHRA Inspections of CROs
pharmafile | January 24, 2012 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Audits, Wainwright Associates, inspectonsÂ
In accordance with the provisions of the new pharmacovigilance legislation, as per Directive 2010/84/EU, EU Competent Authorities may inspect the premises and pharmacovigilance records of both Marketing Authorisation Holders and companies employed by them to perform pharmacovigilance services.
In the UK the MHRA is proposing to establish a scheme to carry out such inspections of service providers. Wainwright Associates’ experienced pharmacovigilance consultants are able to conduct independent audits to enable service providers to prepare for this eventuality.
For further information regarding audits and inspections, please contact us on +44 (0)1628 530554 or email enquiries@wainwrightassociates.co.uk.
Related Content
Submission of labels and leaflets in the UK
The MHRA has announced procedural changes concerning the requirement to submit full-colour mock-ups of labels …
On-going Medicine evaluation Information to be published by European Medicines Agency
Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and …
Payment changes of authority’s fees in France
Changes are being made in the way fees are paid for regulatory submissions and procedures …






